THIOSTREPTON Good Manufacturer supply High Quality 1393-48-2
- Molecular Formula:C72H85 N19 O18 S5
- Molecular Weight:1665.06
- Melting Point:248-257°C (dec.)
- Refractive Index:1.6700 (estimate)
- Boiling Point:°Cat760mmHg
- PKA:10.43±0.46(Predicted)
- Flash Point:°C
- PSA：701.00000
- Density:1.64 g/cm3
- LogP:4.08640
THIOSTREPTON (1393-48-2) Usage
The mammalian transcription factor forkhead box M1 (FoxM1) is induced during G1 phase, with expression continuing through S phase and mitosis. Thiostrepton is a natural peptide thiazole antibiotic that inhibits FoxM1 in mammalian cells, preventing the expression of FoxM1-regulated genes, which includes FoxM1 itself. Through this mechanism, thiostrepton prevents proliferation and induces apoptosis in human cancer cells. These effects correlate with the ability of thiostrepton to act as a proteasome inhibitor.
How to get the best price on THIOSTREPTON?
Zibo Hangyu Biotechnology Development Co., Ltd is a quality supplier and manufacturer of THIOSTREPTON . You can buy high quality, low price THIOSTREPTON 1393-48-2 here.
Zibo Hangyu Biotechnology Development Co., Ltd. is a comprehensive chemical enterprise focusing on fine chemical products and pharmaceutical intermediates, integrating research and development, production and sales. The company is equipped with advanced equipment quality inspection and research center. At the same time, the company has excellent talents with rich experience in process development and quality control. To provide customers with total solutions from raw material processing to chemical synthesis systems. The company has established a standardized and perfect quality standard system to provide stable and high quality production and service.
Milestones
- 2012yearThe company was founded, began to engage in the production and supply of chemical raw materials
- 2014yearExpand the scale of production, pharmaceutical raw materials production workshop was established
- 2016yearCooperated with domestic and foreign chemical platforms to promote self-produced and high-end pharmaceutical intermediates
- 2019yearIn recent years to participate in the international pharmaceutical raw materials exhibitions
- 2023yearBusiness continues to expand, Production and Sales teams continue to grow
- 2026yearPlans to set up foreign branches
